Ex-Dividend Reminder: RLX Technology, Royal Bank of Canada and Diversified Healthcare Trust

Three stocks trade ex-dividend on 2026-01-26: RLX Technology (RLX) with an annual dividend of $0.10 payable 2026-02-09 (implying ~4.42% yield on a recent $2.26 share price and an expected ~4.42% open-price decline), Royal Bank of Canada (RY) with a quarterly dividend of $1.64 payable 2026-02-24 (estimated annualized yield 3.90%, ~0.98% open-price effect), and Diversified Healthcare Trust (DHC) with a quarterly $0.01 dividend payable 2026-02-19 (estimated annualized yield 0.67%, ~0.17% open-price effect). Intraday moves cited: RLX down ~0.4%, RY up ~0.3%, DHC up ~1.9%; the piece is informational on dividend timing, yields and expected ex-dividend pricing effects rather than new corporate developments.

Analysis

Market structure: The ex-dividend mechanics will mechanically pressure RLX by ~4.42% on 1/26/26, RY by ~0.98% and DHC by ~0.17% — creating short-term supply into the open and transient selling flows (day 0–3). RLX (small-cap, -0.15 sentiment) is the direct loser if the dividend is a token payout; RY benefits from steady income demand and rising-rate NIMs, tightening relative bid/ask and options skews on Canadian financials. Cross-asset: expect modest bump in implied volatility and put buying for RLX; RY moves can influence CAD vs USD and swap spreads (sensitivity to +10–30bp Canada curves).

Risk assessment: Tail risks include a regulatory shock to RLX (China vaping restrictions or ADR issues) that could halve market cap (low-probability, high-impact), a Canadian macro/capital event forcing RY to cut distribution, or a DHC reimbursement/occupancy shock hitting FFO >10% down. Timing: immediate (days) = mechanical drop; short-term (weeks) = flows/IV repricing; medium/long (quarters) = dividend sustainability and credit/occupancy trends. Hidden dependencies include tax/withholding on ADRs and borrow costs for shorting (RLX borrow could be >5% p.a.), which change trade economics. Catalysts: earnings (next 30–90 days), Canadian rate decisions, and China regulatory announcements.

Trade implications: Avoid buying RLX into ex-div; use options instead — buy 4–6 week puts or a put spread to limit carry (allocate 0.25–0.75% NAV). Consider establishing a 1–3% long position in RY 1–3 trading days post-ex-div to capture ~3.9% yield plus potential 6–12% price upside over 6–12 months; overlay covered calls 1–3 months OTM to enhance yield. For DHC, avoid long exposure given 0.67% yield and REIT fundamentals risk; short or underweight if FFO guidance misses by >5% or same-store occupancy drops 100bps.

Contrarian angles: Markets may over-penalize RLX for the dividend (mechanical drop often recovers 50–100% of the ex-dividend amount within 5–20 sessions if no news) — a tactical mean-reversion play post-ex-divide is possible but only after verifying liquidity and regulatory status. RY’s dividend durability is underpriced versus Canadian large-cap peers if 10y Canada stays >3.5% — upside skew in 3–6 months. DHC’s token payout suggests management weakness; a pre-emptive short is asymmetric if upcoming releases worsen FFO by >8–10%.

Key Decisions for Investors

• Establish a 1–3% long position in Royal Bank of Canada (RY) within 1–3 trading days after the 1/26/26 ex-dividend date to capture yield (~3.9%) and potential 6–12% price appreciation over 6–12 months; sell 1–2 month OTM calls (covered-call) to boost income and set a hard stop-loss at -8%.
• Do NOT buy RLX into the 1/26/26 ex-dividend; instead allocate 0.5% NAV to a protective trade: buy a 4–6 week put or a put spread (limit premium to 0.25–0.5% NAV) to speculate on downside or hedge existing exposure — avoid naked short because borrow/ dividend-pay obligations materially increase carry (>4%).
• Reduce or avoid long exposure to Diversified Healthcare Trust (DHC); initiate a 1% short position or use inverse healthcare REIT ETF exposure if DHC reports FFO/occupancy miss >5% in next 60 days, with target exit at 15% profit or stop-loss at 6% adverse move.